Hypocrellin A
Hypocrellin A is a PKC inhibitor that exerts antidiabetic activity by reversing the effects of high glucose on endothelin (ET-1) expression. Hypocrellin A is also a photosensitizer for photodynamic therapy (PDT) with anticancer, antibacterial and antiviral activities, especially against human immunodeficiency virus (HIV) . In addition, Hypocrellin-A also possesses anti-Leishmania activity (IC50=0.27 μg/ml) [1][2][3][4][5][6][7][8][9].
Product Specifications
CAS Number
[77029-83-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Bacterial; Bcl-2 Family; HIV; Parasite; PKC; VEGFR; VSV
Type
Natural Products
Related Pathways
Anti-infection; Apoptosis; Epigenetics; Protein Tyrosine Kinase/RTK; TGF-beta/Smad
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hypocrellin-a.html
Purity
99.73
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
COC(C1=O)=C2C3=C(C1=C(C=C4OC)O)C4=C(C(OC)=CC(O)=C56)C5=C3C(CC(C)(O)C2C(C)=O)=C(OC)C6=O
Molecular Formula
C30H26O10
Molecular Weight
546.52
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Leishmania
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items